21/04/2026
Based on reports from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) Yellow Card scheme up to January 2025, there have been 82 deaths in the UK linked to suspected adverse reactions to GLP-1 receptor agonist drugs (including Ozempic, Wegovy, and Mounjaro).
The BMJ
The BMJ
It is important to note that a report to the MHRA does not prove the drug caused the death, only that a reporter suspected a link.